Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
View ORCID ProfileTom M. Quinn, View ORCID ProfileErin E. Gaughan, Annya Bruce, Jean Antonelli, View ORCID ProfileRichard O’Connor, Feng Li, Sarah McNamara, View ORCID ProfileOliver Koch, Claire MacIntosh, View ORCID ProfileDavid Dockrell, View ORCID ProfileTimothy Walsh, View ORCID ProfileKevin G. Blyth, Colin Church, Jürgen Schwarze, Cecilia Boz, Asta Valanciute, View ORCID ProfileMatthew Burgess, Philip Emanuel, Bethany Mills, View ORCID ProfileGiulia Rinaldi, Gareth Hardisty, View ORCID ProfileRoss Mills, View ORCID ProfileEmily Findlay, View ORCID ProfileSunny Jabbal, Andrew Duncan, Sinéad Plant, Adam D. L. Marshall, Irene Young, Kay Russell, Emma Scholefield, Alastair F. Nimmo, Islom B. Nazarov, Grant C. Churchill, View ORCID ProfileJames S.O. McCullagh, View ORCID ProfileKourosh H. Ebrahimi, Colin Ferrett, View ORCID ProfileKate Templeton, Steve Rannard, Andrew Owen, Anne Moore, Keith Finlayson, View ORCID ProfileManu Shankar-Hari, John Norrie, View ORCID ProfileRichard A. Parker, View ORCID ProfileAhsan R. Akram, View ORCID ProfileDaniel C. Anthony, View ORCID ProfileJames W. Dear, Nik Hirani, View ORCID ProfileKevin Dhaliwal
doi: https://doi.org/10.1101/2021.10.06.21264648
Tom M. Quinn
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Erin E. Gaughan
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Annya Bruce
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Jean Antonelli
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Richard O’Connor
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Feng Li
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Sarah McNamara
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Oliver Koch
3Regional Infectious Disease Unit, NHS Lothian
Claire MacIntosh
3Regional Infectious Disease Unit, NHS Lothian
David Dockrell
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
3Regional Infectious Disease Unit, NHS Lothian
Timothy Walsh
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Kevin G. Blyth
4Institute of Cancer Sciences, University of Glasgow
Colin Church
5Department of Respiratory Medicine, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde Health Board, Glasgow, UK
Jürgen Schwarze
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Cecilia Boz
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Asta Valanciute
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Matthew Burgess
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Philip Emanuel
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Bethany Mills
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Giulia Rinaldi
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Gareth Hardisty
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Ross Mills
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Emily Findlay
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Sunny Jabbal
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Andrew Duncan
3Regional Infectious Disease Unit, NHS Lothian
Sinéad Plant
3Regional Infectious Disease Unit, NHS Lothian
Adam D. L. Marshall
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Irene Young
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Kay Russell
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Emma Scholefield
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Alastair F. Nimmo
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Islom B. Nazarov
6Latus Therapeutics, Oxford, UK
7Department of Pharmacology, University of Oxford, Oxford, UK
Grant C. Churchill
7Department of Pharmacology, University of Oxford, Oxford, UK
James S.O. McCullagh
9Department of Chemistry, University of Oxford, Oxford, UK
Kourosh H. Ebrahimi
13Institute of Pharmaceutical Science, King’s College London, UK
Colin Ferrett
8Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Kate Templeton
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Steve Rannard
10Centre of Excellence for Long-acting Therapeutics, Materials Innovation Factory & Department of Pharmacology and Therapeutics, University of Liverpool
Andrew Owen
10Centre of Excellence for Long-acting Therapeutics, Materials Innovation Factory & Department of Pharmacology and Therapeutics, University of Liverpool
Anne Moore
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Keith Finlayson
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
Manu Shankar-Hari
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
John Norrie
11Edinburgh Clinical Trials Unit (ECTU), Usher Institute, University of Edinburgh, Edinburgh, UK
Richard A. Parker
11Edinburgh Clinical Trials Unit (ECTU), Usher Institute, University of Edinburgh, Edinburgh, UK
Ahsan R. Akram
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Daniel C. Anthony
7Department of Pharmacology, University of Oxford, Oxford, UK
James W. Dear
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
12Centre for Cardiovascular Science, Queen’s Medical Research Institute, Bioquarter, University of Edinburgh, Edinburgh, UK
Nik Hirani
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Kevin Dhaliwal
1Centre for Inflammation Research, Queen’s Medical Research Institute, BioQuarter, University of Edinburgh, Edinburgh, UK
2Royal Infirmary of Edinburgh, BioQuarter, Little France, Edinburgh
Data Availability
Ownership of the data arising from this study resides with the study team. Scientific publications and the sharing of clinical data generated as part of this trial is crucial to better understanding COVID-19 and developing new treatments. As such, the results will be submitted for publication in a peer-reviewed journal. Data will be shared with larger clinical trial networks, including RECOVERY.
Posted October 07, 2021.
Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
Tom M. Quinn, Erin E. Gaughan, Annya Bruce, Jean Antonelli, Richard O’Connor, Feng Li, Sarah McNamara, Oliver Koch, Claire MacIntosh, David Dockrell, Timothy Walsh, Kevin G. Blyth, Colin Church, Jürgen Schwarze, Cecilia Boz, Asta Valanciute, Matthew Burgess, Philip Emanuel, Bethany Mills, Giulia Rinaldi, Gareth Hardisty, Ross Mills, Emily Findlay, Sunny Jabbal, Andrew Duncan, Sinéad Plant, Adam D. L. Marshall, Irene Young, Kay Russell, Emma Scholefield, Alastair F. Nimmo, Islom B. Nazarov, Grant C. Churchill, James S.O. McCullagh, Kourosh H. Ebrahimi, Colin Ferrett, Kate Templeton, Steve Rannard, Andrew Owen, Anne Moore, Keith Finlayson, Manu Shankar-Hari, John Norrie, Richard A. Parker, Ahsan R. Akram, Daniel C. Anthony, James W. Dear, Nik Hirani, Kevin Dhaliwal
medRxiv 2021.10.06.21264648; doi: https://doi.org/10.1101/2021.10.06.21264648
Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
Tom M. Quinn, Erin E. Gaughan, Annya Bruce, Jean Antonelli, Richard O’Connor, Feng Li, Sarah McNamara, Oliver Koch, Claire MacIntosh, David Dockrell, Timothy Walsh, Kevin G. Blyth, Colin Church, Jürgen Schwarze, Cecilia Boz, Asta Valanciute, Matthew Burgess, Philip Emanuel, Bethany Mills, Giulia Rinaldi, Gareth Hardisty, Ross Mills, Emily Findlay, Sunny Jabbal, Andrew Duncan, Sinéad Plant, Adam D. L. Marshall, Irene Young, Kay Russell, Emma Scholefield, Alastair F. Nimmo, Islom B. Nazarov, Grant C. Churchill, James S.O. McCullagh, Kourosh H. Ebrahimi, Colin Ferrett, Kate Templeton, Steve Rannard, Andrew Owen, Anne Moore, Keith Finlayson, Manu Shankar-Hari, John Norrie, Richard A. Parker, Ahsan R. Akram, Daniel C. Anthony, James W. Dear, Nik Hirani, Kevin Dhaliwal
medRxiv 2021.10.06.21264648; doi: https://doi.org/10.1101/2021.10.06.21264648
Subject Area
Subject Areas
- Addiction Medicine (353)
- Allergy and Immunology (675)
- Anesthesia (182)
- Cardiovascular Medicine (2675)
- Dermatology (226)
- Emergency Medicine (404)
- Epidemiology (12293)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4144)
- Geriatric Medicine (388)
- Health Economics (683)
- Health Informatics (2685)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (857)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (443)
- Neurology (3927)
- Nursing (212)
- Nutrition (584)
- Oncology (2065)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (306)
- Pain Medicine (251)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1126)
- Primary Care Research (461)
- Public and Global Health (6566)
- Radiology and Imaging (1415)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (189)
- Urology (169)